Contract notice: active substance dexamethasone intravitreales implant,. the dak-g assumes that this procedure does not fall within the scope of antitrust law due to the lack of a selection decision and thus the non-discriminatory accessibility of all pharmaceutical companies. Prerequisites for the conclusion or subsequent accession to the contract
The FDA has handed devicemakers a high-stakes puzzle:. It'd be great to find out what the FDA was actually thinking when it put together that final guidance. Jay Crowley, a 27- year veteran of the FDA, was patient safety advisor to the CDRH until 2014, when he joined the regulatory consulting firm USDM Life Sciences as vice president of its unique
Albany, NY 02/21/2018 New research report offers a comprehensive analysis of the " Durable Medical Equipment Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017- 2025" The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market. Requ
Feb. 21 The opioid epidemic in South Carolina isn't just hurting those who overdose, it's putting a serious toll on hospitals and other patients as well. In 2016, total overdose admissions and emergency department visits cost South Carolina hospitals an estimated $58.6 million, according to a report from the Medical University of South Carolina.
New York, NY 02/21/2018 The latest industry intelligence research on the Medical Device Connectivity market offers a repository of valuable data on the size, share, and growth rate of the Medical Device Connectivity market for the forecast period, 2018- 2025. Importantly, examination of various facets of the industry including but not limited
Albany, NY 02/21/2018 Medical imaging is used to define the use of conventional and sophisticated diagnostic practices. Traditional imaging techniques like computed tomography, magnetic resonance imaging, ultrasound, X-ray, and nuclear medicine usually analyze morphology and anatomy but are unable to detect changes at the molecular level.
2018 is shaping up to be an exciting year for Tandem Diabetes Care thanks to its application made to Health Canada announced on Tuesday.. This diabetes care focused company is the only to manufacture an insulin pump with a touchscreen and is now hoping to break into the Canadian diabetes market with a Health Canada medical device license. This a
Global healthcare cybersecurity is anticipated to spend more than $65 billion to 2021, and ransomware attacks on healthcare organizations are predicted to quadruple by 2020, according to a Cybersecurity Ventures report, noting that hospitals are most at risk. In 2017, 21st Century Oncology agreed to pay a $2.3 million fine on December 12, 2017 to t
By a News Reporter-Staff News Editor at Telecommunications Weekly A patent application by the inventors Carrender, Curtis L.; Morrisey, Daniel; Sainion, Soneer, filed on July 28, 2017, was made available online on February 8, 2018, according to news reporting originating from Washington, D.C., by VerticalNews correspondents. This patent applicati
NORTH CHICAGO- AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer's disease and..
AbbVie, a global biopharmaceutical company, and Voyager Therapeutics, Inc., a clinical-stage gene therapy company, today announced that they have entered into an exclusive strategic collaboration and option agreement to develop and commercialize vectorized antibodies directed against tau for the treatment of Alzheimer`s disease and other...
AbbVie, a global research and development-based biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc., announced that the Phase 3 ELARIS UF-I study of elagolix met its primary endpoint. Uterine fibroids are the most common type of abnormal growth in a woman's pelvis and can affect up to 80 percent of women by age 50. 1 Fibro
AbbVie will partner with Voyager Therapeutics to develop and commercialize gene therapies for Alzheimer`s disease and other neurodegenerative diseases, through a collaboration that could generate more than $1.1 billion- plus for Voyager, the companies said today. Voyager`s vectorized antibody platform presents an innovative approach to addressing..
BARCELONA, Catalonia, Spain- Ability Pharmaceuticals SL, a biopharmaceutical company announced today that the United States Food and Drug Administration has approved a phase 1/ 2 study to assess the efficacy and safety of ABTL0812 in combination with gemcitabine and nab-paclitaxel in patients with advanced metastatic pancreatic cancer at first line
BOTHELL, Washington and VANCOUVER- Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced preliminary data from their Phase I/II multi-dose, pharmacokinetic and pharmacodynamics clinical study of cytisine.
Dr. Breidbart is an accomplished managed care executive with over 20 years of experience driving quality improvement and establishing quality-based payment models. Most recently, Dr. Breidbart was the Chief Medical Officer at Solera Health in Phoenix, Arizona, where he was instrumental in strengthening the partnership between the company s healt
The American Hospital Association issued the following statement by President and CEO Rick Pollack on proposed short-term health insurance plans:. "Patients and families depend on health insurance to access and be able to afford the care they need when they need it. Today's proposed rule is a step in the wrong direction for patients and health car
Four months after DBV Technologies stock was crushed by a shaky set of pivotal data for its peanut allergy drug, rival Aimmune Therapeutics$ AIMT says its Phase III has come through with a promising set of results. And the win sets up an FDA application later this year for the pioneering drug, with a European pitch to follow soon after. Its great t
Aldeyra Therapeutics, Inc., a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with inflammatory diseases, today announced that the results of the Phase 2 a clinical trial of topical ocular reproxalap in dry eye disease were selected for podium presentation at the 2018 Association for Rese
Mr. Mattacchione succeeds Felicia Ladin, who announced her intention to leave AMRI in December 2017. Mr. Mattacchione has more than 30 years of experience in financial leadership positions with high growth companies across the life sciences tools, biopharmaceutical, chemicals and technology sectors. Before joining AMRI, Mr. Mattacchione spent five
-Amunix Operating Inc., a biopharmaceutical company focused on the discovery and development of novel immuno-oncology therapeutics, is pleased to announce that it has entered into a licensing agreement with Celgene. The agreement allows for the utilization of Amunixs proprietary XTEN and ProTIA technology to augment ongoing discovery and developmen
References in this Annual Report on Form 10- K to the terms "we," "our," "us," "Anthem" or the "Company" refer to Anthem, Inc., an Indiana corporation, and, unless the context otherwise requires, its direct and indirect subsidiaries. References to the term "states" include the District of Columbia, unless the context otherwise requires. Our Governm
Albany, NY 02/21/2018 Antigens are used for the production of antibodies. These can be toxins or other substances, which induce an immune response in the body. The global Antigen Kit Market is expected to grow in the near future owing to increasing demand for antigen kit in various application segments such as rapid medical diagnostics, in vi
AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the US Food and Drug Administration has approved Imfinzi for the treatment of patients with unresectable Stage III non-small cell lung cancer whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.